Selective decontamination of subglottic area in mechanically ventilated patients with multiple trauma.
OBJECTIVE
To determine whether selective decontamination locally in the subglottic area (SDSA) reduces tracheal colonization and prevents ventilator-associated pneumonia (VAP) in patients with multiple trauma.


METHODS
A prospective randomized, controlled, clinical study in a 14-bed general intensive care unit of a university hospital.


METHODS
79 consecutive multiple trauma patients admitted to the ICU who were expected to be mechanically ventilated for more than 5 days; 61 patients completed the protocol.


METHODS
Patients were randomly assigned to receive SDSA using a continuous infusion of a suspension containing three nonabsorbable antibiotics (polymyxin, tombramycin, and amphotericin B; n=30) or placebo ( n=31).


METHODS
The incidence of bronchial and gastric colonization and the number of cases of VAP were recorded. Gastric fluid and tracheal secretion cultures were obtained soon after intubation and thereafter every 4 days. Etiological diagnosis of VAP was based on samples taken by a specific protected double catheter set.


RESULTS
VAP developed in 5 of 30 (16.6%) patients receiving SDSA and 16 of 31 (51.6%) patients receiving placebo. Negative bronchial secretion cultures were found in 14 of 30 (46.6%) patients in the SDSA group and in only 3 of 31 (9.6%) patients in the control group. No patient with negative bronchial secretion culture developed VAP. No significant differences in outcome were found.


CONCLUSIONS
The SDSA is an effective and safe type of chemoprophylaxis against tracheal colonization and can significantly reduce the incidence of VAP in mechanically ventilated patients with multiple trauma.
Pneumatikos
Ioannis
I
Intensive Care Unit, University Hospital of Ioannina, University Street, 45500 Ioannina, Greece.
Koulouras
Vassilios
V
Nathanail
Christodoulos
C
Goe
Diana
D
Nakos
George
G
D000328:Adult; D019072:Antibiotic Prophylaxis / Q000379:methods*; D001424:Bacterial Infections / Q000517:prevention & control; D016009:Chi-Square Distribution; D003428:Cross Infection / Q000517:prevention & control; D005260:Female; D006801:Humans; D008297:Male; D009104:Multiple Trauma / Q000628:therapy*; D018410:Pneumonia, Bacterial / Q000209:etiology / Q000517:prevention & control*; D011446:Prospective Studies; D012121:Respiration, Artificial / Q000009:adverse effects*; D014132:Trachea / Q000382:microbiology